Repository of Research and Investigative Information

Repository of Research and Investigative Information

Ilam University of Medical Sciences

Heteroresistance to clarithromycin and metronidazole in patients with a Helicobacter pylori infection: a systematic review and meta-analysis

Thu Feb 2 17:33:55 2023

(2022) Heteroresistance to clarithromycin and metronidazole in patients with a Helicobacter pylori infection: a systematic review and meta-analysis. Annals of Clinical Microbiology and Antimicrobials. p. 8.

Full text not available from this repository.

Official URL: http://apps.webofknowledge.com/InboundService.do?F...

Abstract

Background Antimicrobial resistance of H. pylori can lead to treatment failure. Importantly, several studies have reported on heteroresistance, i.e. the presence of resistant and susceptible H. pylori populations in the same sample and/or a difference in the susceptibility patterns between biopsy samples. This meta-analysis aims to provide comprehensive data on the prevalence of metronidazole and clarithromycin heteroresistance and the approaches to their detection. Material and methods A systematic review was performed after the search of MEDLINE, Scopus and Web of Science. The study outcomes were the weighted pooled prevalence of heteroresistance to clarithromycin and metronidazole in H. pylori positive samples and/or isolates with a subanalysis by continent. Results A total of 22 studies that had investigated 3852 H. pylori positive patients were included in the meta-analysis. Heteroresistance to clarithromycin was reported in 20 studies, with a weighted pooled prevalence of 6.8 (95 CI 5.1-8.6; 3654 H. pylori positive patients; the substantial heterogeneity I-2 = 55.6). Heteroresistance to metronidazole was reported in 12 studies, with a weighted pooled prevalence of 13.8 (95 CI 8.9-18.6; 1670 H. pylori positive patients; the substantial heterogeneity I-2 = 60.9). The weighted pooled prevalence of clarithromycin heteroresistance was similar in Asia and Europe (p = 0.174584), however, metronidazole heteroresistance was detected more often in Europe (p < 0.00001). Clarithromycin heteroresistance was detected more often by phenotype rather than by using genotyping methods (12 vs 8 studies), whereas heteroresistance to metronidazole was detected only by phenotype. Conclusion The prevalence of heteroresistance to clarithromycin and/or metronidazole is not negligible and can be detected in approximately 7 and 14 of H. pylori positive samples, respectively. These findings highlight the need to raise the awareness of gastroenterologists and microbiologists to the heteroresistance to clarithromycin and metronidazole in patients with a H. pylori infection.

Item Type: Article
Creators:
CreatorsEmail
Kouhsari, E.UNSPECIFIED
Sadeghifard, N.UNSPECIFIED
Khadiv, A.UNSPECIFIED
Sayadi, H.UNSPECIFIED
Amiriani, T.UNSPECIFIED
Ghafourian, S.UNSPECIFIED
Valadbeigi, H.UNSPECIFIED
Krutova, M.UNSPECIFIED
Keywords: antibiotic-resistance susceptibility gastritis genotypes biopsies multiple stomach corpus antrum Microbiology
Divisions:
Page Range: p. 8
Journal or Publication Title: Annals of Clinical Microbiology and Antimicrobials
Journal Index: ISI
Volume: 21
Number: 1
Identification Number: https://doi.org/10.1186/s12941-022-00509-3
Depositing User: مهندس مهدی شریفی
URI: http://eprints.medilam.ac.ir/id/eprint/3928

Actions (login required)

View Item View Item